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The GRIP domain is a targeting sequence found in a
family of coiled-coil peripheral Golgi proteins. Previ-
ously we demonstrated that the GRIP domain of p230/
golgin245 is specifically recruited to tubulovesicular
structures of the trans-Golgi network (TGN). Here we
have characterized two novel Golgi proteins with func-
tional GRIP domains, designated GCC88 and GCC185.
GCC88 cDNA encodes a protein of 88 kDa, and GCC185
cDNA encodes a protein of 185 kDa. Both molecules are
brefeldin A-sensitive peripheral membrane proteins
and are predicted to have extensive coiled-coil regions
with the GRIP domain at the C terminus. By immuno-
fluorescence and immunoelectron microscopy GCC88
and GCC185, and the GRIP protein golgin97, are all lo-
calized to the TGN of HeLa cells. Overexpression of full-
length GCC88 leads to the formation of large electron
dense structures that extend from the trans-Golgi.
These de novo structures contain GCC88 and co-stain for
the TGN markers syntaxin 6 and TGN38 but not for
2,6-sialyltransferase, -COP, or cis-Golgi GM130. The
formation of these abnormal structures requires the N-
terminal domain of GCC88. TGN38, which recycles be-
tween the TGN and plasma membrane, was trans-
ported into and out of the GCC88 decorated structures.
These data introduce two new GRIP domain proteins
and implicate a role for GCC88 in the organization of a
specific TGN subcompartment involved with membrane
transport.
The trans-Golgi network (TGN)1 is a highly dynamic and
complex membrane network that represents a major protein
sorting compartment of the secretory pathway. From the TGN,
proteins are shunted into distinct transport carriers for trans-
port to the plasma membrane, regulated secretory granules,
different populations of endosomes, or earlier compartments of
the secretory pathway (1, 2). A fundamental, unresolved ques-
tion in cell biology is how the Golgi apparatus is formed and in
particular how the TGN maintains a highly dynamic tubulove-
sicular structure and generates the diverse populations of
TGN-derived transport carriers. A number of Golgi matrix
proteins have been identified, for example GRASP55 and Gol-
gin-45, which may be involved in the maintenance of the me-
dial-Golgi structure (3, 4). Little, however, is known about a
matrix associated with the trans-Golgi responsible for generat-
ing or maintaining the tubulovesicular structure of the TGN
(5–7). There is growing evidence that components of the Golgi
matrix interface with components of the trafficking machinery
(8, 9). Unique sets of accessory molecules dictate the budding of
transport vesicles and their subsequent docking on specific
membrane domains. Many of these proteins are peripheral
membrane proteins that are recruited to the donor membrane
in a highly regulated manner. For example, on the TGN the
AP-1 adaptor complex is involved in the formation of clathrin-
coated vesicles whereas other heterotetrameric adaptors, AP-3
and AP-4, and the GGA (Golgi-localizing, -adaptin ear homol-
ogy, ARF-binding) proteins are recruited to distinct TGN do-
mains involved in the formation of both clathrin and non-
clathrin-coated vesicles (10, 11). However, the specific
membrane association of many of these components and the
basis for the domain-specific organization of the TGN is poorly
defined.
Recently we and others (12–14) have identified a family of
Golgi coiled-coil peripheral membrane proteins in animal and
yeast cells that contain a conserved 42-amino acid sequence
at the C terminus, called the GRIP domain. The level of se-
quence identity between the GRIP domains is only modest;
however, functional assays have demonstrated that a number
of different GRIP sequences can specifically target reporter
molecules to the Golgi apparatus. By analysis of chimeric green
fluorescent proteins (GFP), the GRIP domain has been shown
to be both necessary and sufficient for Golgi targeting in animal
cells (12–15). Furthermore, the GRIP domain of one family
member, p230, has been shown to target specifically to the
TGN of mammalian cells (16). In addition, we have also iden-
tified recently a coiled-coil protein with a GRIP sequence in
protozoan parasites and shown that the GRIP domain was
specifically recruited to the TGN in the trypanosomatid para-
site, Leishmania mexicana (17). The identification of GRIP
domain proteins associated with the TGN of this very primitive
protozoan eukaryotic cell suggests that these coiled-coil pro-
teins play a fundamental role in the organization and/or func-
tion of this highly dynamic Golgi compartment.
In Saccharomyces cerevisiae, only one coiled-coil protein with
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a GRIP domain has been identified. This protein, Imh1p, is a
suppressor of a temperature-sensitive yeast strain that lacks a
functional GTPase Rab6 homologue, Ypt6p (18, 19). In contrast
a number of proteins with potential GRIP domains have been
identified in mammalian cells, including the two characterized
Golgi proteins, p230/golgin245 and golgin97. p230/golgin245
binds to the TGN in a brefeldin A-sensitive manner (15, 20).
Recent studies have shown that endogenous p230 and a GFP
chimera containing the p230-GRIP sequence binds to a subdo-
main of the TGN that forms highly dynamic tubular vesicular
extensions that have the characteristics of transport carriers
(16, 20). Furthermore, the GFP-p230GRIP chimera has been
shown to be associated with a population of in vitro generated
vesicles that lack markers (-COP, -adaptin, Rab6, and p200/
myosin II) associated with other TGN-derived vesicles (16). The
extended coiled-coil structure of the GRIP domain proteins
links them to the broader family of Golgi coiled-coil proteins
known as golgins, which are proposed to function as molecular
tethers in the docking of transport vesicles with a target mem-
brane and in the maintenance of Golgi structure (21).
In addition to p230 and golgin97, data base searches also
identified two other putative human coiled-coil proteins with
GRIP domains, referred to previously as GCC1p (Golgi local-
ized coiled-coil protein) and KIAA0336 (13). By the analysis of
GFP fusion proteins, the GRIP domain of GCC1p was shown to
function as a Golgi targeting signal in transfected cells. The
predicted GCC1p sequence was derived from a DNA cosmid
sequence (g1572c101) and required prediction of exon/intron
boundaries (13). The human expressed sequence tag sequence,
KIAA0336 (GenBankTM accession number AB002334), is pre-
dicted to encode a coiled-coil protein of 1583 amino acids. The
GRIP sequence of KIAA0336 has not yet been analyzed exper-
imentally; however it is predicted to contain the highly con-
served Tyr (or Phe) residues at positions 4 and 12 of the
domain, aromatic residues that are essential for the GRIP
domain to function in Golgi targeting. These findings raised a
number of questions. First, are GCC1p and KIAA0336 bona
fide Golgi proteins? Second, in view of the modest sequence
similarity between GRIP domains, are the different GRIP do-
mains localized to the same or different regions of the Golgi
apparatus? Third, how many mammalian GRIP proteins are
found in one particular cell type? Finally, do all the mamma-
lian GRIP proteins have similar functions? In the present study
we report on the full-length sequences of both novel human
GRIP proteins, which we now call GCC88 (for GCC1p) and
GCC185 (for KIAA0336), and demonstrate that they are both
localized to the TGN in HeLa cells, along with the other two
GRIP family members p230 and golgin97. Altogether, our data
show that four different brefeldin A-sensitive GRIP proteins
are associated with the TGN of mammalian cells. We further
show that GCC88 overexpression results in a major perturba-
tion of a domain of the TGN associated with the membrane
transport of TGN38.
EXPERIMENTAL PROCEDURES
Antibodies—Human autoantibodies to p230 have been described
(22). The 9E10 mouse monoclonal antibody specific for the myc epitope
has been described (23). The P5D4 mouse monoclonal antibody that
recognizes the VSV-G epitope was described by Kries (24). Rabbit
polyclonal antibodies to -COP were kindly provided by Dr. R. Teasdale
(University of Queensland, Brisbane, Queensland, Australia). A mono-
clonal antibody to GFP, purchased from Roche Molecular Biochemicals,
was used at dilutions of 1/1000 for immunoblotting. Monoclonal anti-
bodies to golgin97, syntaxin 6, GM130, and TGN38 were purchased
from Transduction Laboratories (Lexington, KY). For electron micros-
copy, a polyclonal anti-GFP (Molecular Probes) was used at 1/500 dilu-
tion. Sheep anti-rabbit Ig-FITC, sheep anti-mouse Ig-FITC, and sheep
anti-human IgG-FITC were purchased from Silenus Laboratories
(Melbourne, Victoria, Australia), goat anti-rabbit IgG-Texas Red, goat
anti-mouse IgG-Texas Red, goat anti-mouse IgG-Alexa Fluor 568, and
goat anti-human IgG-Alexa Fluor 594 were from Molecular Probes.
Horseradish peroxidase-conjugated rabbit anti-mouse Ig and porcine
anti-rabbit Ig were obtained from DAKO corporation (Carpinteria, CA).
Cell Culture and Transfection—HeLa, COS, and normal rat kidney
(NRK) cells were maintained as monolayers in Dulbecco’s modified
Eagle’s medium (DMEM), supplemented with 5% fetal calf serum, 2 mM
glutamine, and 100 g/ml penicillin/streptomycin, in a humidified 37 °C
incubator with 10% CO2. Stable HeLa cells expressing 2,6-sialyltrans-
ferase (SialylT) tagged at the C terminus with a VSV-G epitope (25)
were generously supplied by Dr. T. Nilsson and were grown in the above
medium supplemented with 500 g/ml G418 (Invitrogen). Transient
transfections of cells were performed using FuGENE transfection rea-
gent (Roche Molecular Biochemicals) as described previously (16).
Reverse Transcriptase Polymerase Chain Reaction and Cloning of
GCC88—HeLa cell RNA was isolated using the RNAqueous kit accord-
ing to the manufacturer’s instructions (GeneWorks). cDNA was pre-
pared from HeLa RNA using Superscript (Invitrogen) and oligo(dT)
(Promega) primer. GCC88 cDNA was amplified as four overlapping
fragments that collectively spanned the entire length of the open read-
ing frame predicted from the genomic sequence. Fragment 1 (bases
1–783) was amplified using the primers CCGGAATTCCACCATGGAG-
AAGTTTGGGATG and CGCGGATCCGCGCTGGGTCCTCTCCTCC-
TG. Fragment 2 (bases 715–1293) was amplified using the primers
CCGGAATTCCGAGCAGAGTGACCATGCCTTG and CGCGGATCCG-
ACATTGACATCCAGACTGGA. Fragment 3 (bases 1189–1798) was
amplified using the primers CCGGAATTCCCGCATTCTGCAGCTG-
GAC and CGCGGATCCCTTCTCGGTGAGCACAGCTAG. Fragment 4
(bases 1729–2328) was amplified using the primers CCGGAATTCCC-
GCACACTGAAACTGGAG and CGCGGATCCTCATCTCTTGCCAGA-
AGG. Sequences 5 to the predicted ATG start codon of GCC88 were
amplified using the 5 rapid amplification of cDNA ends method (In-
vitrogen). Each PCR product was subcloned into the EcoRI/BamHI sites
of pGEX-6P-3, except for fragment 4, which was subcloned into the
EcoRI/BamHI sites of pEGFP-C1 (Clontech), and both strands were
sequenced using automated DNA sequencing. Fragments were then
assembled into full-length cDNA using convenient restriction sites and
cloned into pCIneo (Promega).
DNA Constructs—GFP-GCC88GRIP, GFP-p230GRIP, and GFP-
golgin97GRIP were described previously (13, 15). A construct encoding the
full-length GCC88 with a triple myc epitope tag fused to the N terminus
was generated by subcloning the full-length coding region of GCC88 from
pCIneo-GCC88 into pCMU-3xMyc (supplied by Dr. Rohan Teasdale).
To generate a construct that lacked 279 amino acids from the N
terminus of GCC88, pCMU-3xMyc-GCC88 was digested with BamHI
and NdeI to remove an 885-bp fragment between the 3 end of the c-myc
coding region and the NdeI site within GCC88. Following Klenow
treatment to fill recessed 3 ends, the digested vector was self-ligated.
The sequence encoding the C-terminal 82 amino acids of GCC185
was amplified from pBluescript-SK-KIAA0336 (provided by Kazusa
DNA Research Institute) using the primers CCGGAATTCCTTGGAA-
AGGAATCAAGAG and CCGGAATTCCTATCGAAGTCCAGACCA. The
PCR product was digested with EcoRI and cloned into the EcoRI site of
pEGFP-C1 (GFP-GCC185GRIP). The full-length 6.8-kb GCC185 cDNA
was subcloned into pCIneo (Promega) using XhoI and SacII.
Glutathione S-transferase (GST) fusion proteins were constructed
using pGEX-6P-3 (Pharmacia). The sequence encoding the C-terminal
82 amino acids of GCC185 was subcloned from the pEGFP-GCC185GRIP
plasmid into the EcoRI site of the pGEX-6P-3 plasmid (GST-
GCC185GRIP). The sequence encoding the C-terminal 199 amino acids of
GCC88, derived from a PCR product, was subcloned into the EcoRI/
SmaI site of pGEX-6P-3 (GST-GCC88C199aa).
Generation of Anti-GCC88 and Anti-GCC185 Antibodies—Polyclonal
anti-GCC185 antiserum was prepared by immunizing a rabbit with the
GST-GCC185GRIP fusion protein, comprising the C-terminal 82 amino
acids of GCC185 fused to the C terminus of GST. The GST fusion
protein was purified from a bacterial extract on a column of glutathione-
agarose (Sigma) by the method described (22).
Polyclonal rabbit anti-GCC88 antiserum was prepared by immuniz-
ing a rabbit with the C-terminal 199 residues of GCC88. This immuno-
gen was produced by first generating a fusion protein comprising the
C-terminal 199 amino acids of GCC88 fused to the C terminus of GST
(GST-GCC88C199aa). GCC88C199aa polypeptide was then cleaved from
the purified GST fusion protein using Prescission Protease (Amersham
Biosciences) and purified.
Rabbits were immunized three times with 50–100 g of immunogen
emulsified with Freund’s complete adjuvant or Freund’s incomplete
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adjuvant. A terminal bleed was collected by cardiac puncture 12 days
after the final injection.
Immunofluorescence—Cells were processed for immunofluorescence
as described previously (15) and examined by confocal microscopy using
a Bio-Rad MRC-1024 imaging system. For dual labeling, images were
collected independently to ensure there was no spillover of fluorescence
between channels.
Membrane Fractionation—Subconfluent monolayers of HeLa cells
were detached by scraping into PBS and washed in chilled hypotonic-
sucrose buffer (250 mM sucrose, 10 mM HEPES, pH 7.4), containing
Complete Protease Inhibitors (Roche Molecular Biochemicals, Germa-
ny). Cells were resuspended in 500 l of hypotonic-sucrose buffer and
passaged 20 times through a 26-gauge needle. Intact cells and nuclei
were removed by centrifugation at 2,700  g for 10 min, and the
resulting supernatant was centrifuged at 100,000  g at 2 °C for 60
min. The resulting microsome pellet was resuspended in hypotonic
sucrose buffer. Equivalent proportions of each fraction were analyzed
by SDS-PAGE and immunoblotting.
Brefeldin A Treatment—Cell monolayers were treated with 5 g/ml
brefeldin A (Calbiochem) diluted in complete DMEM at 37 °C. Follow-
ing treatment, cells were washed three times in PBS, fixed, and pro-
cessed for immunofluorescence.
Immunoblotting—Cell extracts were dissolved in reducing sample
buffer and subjected to SDS-PAGE. Proteins were then transferred to
nitrocellulose membrane, and the membrane was blocked with 5% skim
milk powder in PBS for 2 h. Antibodies were diluted in PBS containing 5%
(w/v) skim milk powder and incubated on the membrane for 1 h, followed
by three 10-min washes in 0.05% Tween 20/PBS. Membranes were then
incubated with peroxidase-conjugated anti-mouse or rabbit antibodies, as
appropriate, and bound antibodies were detected by enhanced chemilu-
minescence (PerkinElmer Life Sciences) as described (20).
Immunogold Labeling and Electron Microscopy—For immunogold
labeling, subconfluent monolayers of untransfected or transfected HeLa
cells were washed with PBS and fixed with buffered 4% paraformalde-
hyde (electron microscopy grade; ProSciTech), containing 0.2 M sucrose
and then scraped from the dishes and resuspended in 10% gelatin and
infiltrated with 15% polyvinyl-pyrrolidone (Sigma) in 1.7 M sucrose
before snap freezing. Preparation of ultra thin cryosections and immu-
nogold labeling were carried out as described previously (16). Sections
were labeled with antibodies to GFP, myc, syntaxin 6, and GCC88,
either singly or in combination. Rabbit antibodies were detected with
protein A-gold conjugates (gift from Dr. J. Slot, University of Utrecht),
and mouse antibodies were labeled with goat anti-mouse gold (British
Biocell).
TGN38 Internalization—NRK cells, grown on coverslips in complete
DMEM, were transfected with myc-GCC88 24–36 h before treatment.
Cells were then washed twice in PBS and incubated in serum-free
DMEM containing 1.25 g/ml mouse anti-TGN38 monoclonal antibody
for the indicated time period at 37 °C or on ice. As controls, cells were
incubated in either serum-free DMEM alone or irrelevant antibody
(anti-VSV-G epitope monoclonal antibody P5D4) at 37 °C for 90 min.
Monolayers were then washed four times in PBS and fixed immediately
in 4% paraformaldehyde/PBS for 15 min. Cells were processed as for
immunofluorescence and stained with sheep anti-mouse Ig-FITC, fol-
lowed by rabbit anti-GCC88 and finally goat anti-rabbit IgG-Texas Red.
RESULTS
Identification of Two Novel Golgi Proteins with Functional
GRIP Domains, GCC185 and GCC88—Previously, we estab-
lished that the defined Golgi proteins, p230/golgin245 and gol-
gin97, contained functional GRIP domains (13). Data base
searches identified two other putative human proteins with
similar GRIP domains that are predicted to contain extensive
coiled-coil regions. One of the putative proteins was predicted
from genomic sequences and referred to previously as GCC1p
(Golgi localized coiled-coil protein). We established that the
GRIP sequence of this putative protein represented a func-
tional Golgi targeting domain, as a fusion with GFP was effi-
ciently targeted to the Golgi of transfected COS cells (13). As
the predicted GCC1p protein was based on the sequence of a
putative gene within the human genomic cosmid g1572c101
(GenBankTM accession number HSAC000357), requiring pre-
diction of intron/exon boundaries, we have analyzed the se-
quence of this protein. cDNA clones of GCC1p were obtained by
reverse transcriptase PCR using HeLa cell RNA as described
under “Experimental Procedures.” 5 sequence of the mRNA
was obtained using rapid amplification of cDNA ends. Together
the clones comprise 2522 bp, and an open reading frame of
GCC1 cDNA spans an in-frame ATG initiation codon at nucle-
otide position 194 bp and a TGA termination at nucleotide
position 2519 bp. The open reading frame encodes a protein of
775 amino acids with an expected molecular mass of 87.8 kDa
(Fig. 1B); therefore we now call this protein GCC88. A plot of
hydrophilicity suggests GCC88 is a predominantly hydrophilic
structure, with no evidence for a signal sequence or hydropho-
bic transmembrane domain, consistent with a peripheral mem-
brane protein. Analysis of the sequence for coiled coils showed
that a considerable portion (80%) of the molecule had a high
probability of assuming a coiled-coil structure, typical of other
GRIP proteins. There are a number of interruptions in the
predicted coiled-coil structure, suggesting GCC88 adopts a rod-
like structure with periodic flexible joints. Non-coiled-coil re-
gions of the molecule include a 75 residue segment close to
the N terminus and the C-terminal GRIP domain (Fig. 1C).
FIG. 1. Analysis of the sequences of GCC88 and GCC185. A, alignment of the GRIP sequences of g1572c101 (GCC1p/GCC88), KIAA0336
(GCC185), golgin97, and p230. Asterisks indicate identity, and single and double dots represent degrees of similarity. B, predicted amino acid
sequence of GCC88 based on cDNA sequence. The GRIP domain is shaded. C, prediction of coiled-coil segments of GCC88 and GCC185 based on
the method of Lupas et al. (32). D, confocal fluorescence images of COS cells transfected with GFP-GCC185GRIP, GFP-GCC88GRIP, or GFP-p230GRIP,
as indicated. Cells were fixed 48 h after transfection. Bar, 10 m.
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The second putative human protein with a predicted GRIP
domain was based on the sequence of an expressed sequence
tag, KIAA0336, and is predicted to encode a protein of 1583
amino acids (calculated molecular mass of 185 kDa) with ex-
tensive coiled-coil domains spanning almost the entire length
of the protein and a potential non-coiled-coil GRIP domain at
its C terminus (Fig. 1C). We call this protein GCC185. The lack
of a signal sequence or transmembrane domain is consistent
with it also being a peripheral membrane protein. In view of
the low sequence similarity between the GRIP domain se-
quences (Fig. 1A) it is important to determine whether the
GRIP domain of GCC185 is a functional Golgi targeting se-
quence. The cDNA encoding the 200 C-terminal residues of
KIAA0336 was isolated by reverse transcriptase PCR of HeLa
cell RNA, and the sequence of the GRIP domain was shown to
be identical to that found in the data base. We constructed a
chimeric cDNA encoding the non-coiled-coil C-terminal domain
of GCC185 (82 residues), which includes the GRIP domain,
fused to the C terminus of GFP. COS cells transfected with the
GFP-GCC185-GRIP construct showed targeting of GFP fluo-
rescence to the Golgi region of the transfected cells, as indi-
cated by the concentrated juxtanuclear fluorescence, with a
similar staining pattern to GFP-GCC88GRIP and GFP-
p230GRIP. Therefore, even though the sequence similarity be-
tween the GRIP domains is modest, the GRIP sequence of
GCC185 is a functional Golgi targeting motif.
To determine whether the two novel human proteins are
bona fide Golgi proteins, we generated rabbit antisera to the
C-terminal domains of either GCC88 or GCC185 as described
under “Experimental Procedures.” Because the antibodies were
generated to sequences that included GRIP domains, we were
cognizant of the possibility for cross-reactivity of the antiserum
with other members of the GRIP family. Therefore, we assessed
the ability of the antisera to cross-react with GRIP domains of
the other mammalian members of the family (p230, golgin97,
GCC88, and GCC185). Fusions with GFP were analyzed to
avoid cross-reactivity of antibodies with the GST. COS cells
were transiently transfected with GFP constructs, and cell
extracts were immunoblotted with the antisera. As expected,
the antisera raised to GCC88C199aa reacted strongly to the
47-kDa GFP-GCC88C199aa, and importantly no cross-reactivity
was observed with GFP-GCC185GRIP, GFP-p230GRIP, or GFP-
golgin97GRIP fusion protein (Fig. 2A). Blotting with anti-GFP
antibodies demonstrated the presence of abundant levels of
each fusion protein on the membrane blot (Fig. 2A). Likewise,
antibodies to GCC185 showed a strong reactivity to the 35-kDa
GFP-GCC185GRIP fusion protein but no cross-reactivity to fu-
sion proteins containing GRIP sequence of p230, golgin97, or
GCC88 (Fig. 2B). The band observed at 32 kDa with the anti-
GCC185 serum, which does not correspond to sizes of any of the
GFP fusion proteins, is nonspecific.
Immunofluorescence of transfected COS cells was also per-
formed to ensure the two antisera did not cross-react with
other GRIP domains in native rather than denatured pro-
teins. COS cells transfected with GFP-GCC88GRIP stained
strongly with the anti-GCC88 antibody, and the anti-GCC88
staining co-localized with the GFP fluorescence, demonstrat-
ing that the antibody was binding to the GFP fusion protein.
On the other hand, COS cells expressing GFP-GCC185GRIP,
GFP-p230GRIP, or GFP-golgin97GRIP showed no staining with
the anti-GCC88 antibody (not shown). Similarly, the anti-
GCC185 antibody recognized the GFP-GCC185GRIP fusion
protein in transfected COS cells but showed no cross-reactiv-
ity with the other three GFP-GRIP fusion proteins (not
shown). Collectively, these data demonstrate that the anti-
FIG. 2. Specificity of rabbit anti-GCC88 and anti-GCC185 anti-
bodies. Immunoblot analysis of anti-GCC88 (A) and anti-GCC185 (B)
with extracts of COS cells transfected with wild type GFP, GFP-
GCC88GRIP, GFP-GCC185GRIP, GFP-p230GRIP, GFP-golgin97GRIP, or
with GFP fused to the C-terminal 199 residues of GCC88 (GFP-
GCC88C199aa). Blots were incubated with either anti-GFP or anti-GCC
antibodies, as indicated, followed by peroxidase-Ig conjugates, and the
bound antibodies were detected by chemiluminescence.
FIG. 3. Membrane association of endogenous GCC88 and
GCC185 and expression of transfected cDNAs. A and B, analysis of
membrane association of GCC88 and GCC185. Triton X-100 cell ex-
tracts, total membranes, and cytosol fractions were prepared from
HeLa cells, separated by SDS-PAGE, and subjected to immunoblot
analysis using pre-immune and immune rabbit sera to GCC88 (A) or
GCC185 (B). C, COS cells were transiently transfected with pCIneo-
GCC88 or pCIneo-GCC185, and the extracts were immunoblotted. Un-
transfected and transfected cell extracts were immunoblotted with anti-
GCC88 and anti-GCC185, as indicated. The ratio of untransfected to
transfected cell extracts loaded was 500:1 for GCC88 transfected cells
and 1:1 for GCC185 transfected cells.
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GCC88 and anti-GCC185 antibodies are specific for the pro-
teins against which they were raised.
Immunoblotting of HeLa cell extracts with anti-GCC88 an-
tibody detected a single specific component of  105 kDa, an
apparent molecular mass slightly larger than the predicted 88
kDa. Fractionation of HeLa cells showed that the 105-kDa
component was associated with both the membrane and cyto-
solic fraction, indicative of a peripheral membrane protein (Fig.
3A). To ensure that the cDNA encoding GCC88 we had isolated
was full-length, we expressed the GCC88 cDNA in COS cells
and immunoblotted cell extracts with anti-GCC88 antibody. In
untransfected COS cells, a weak band of 105 kDa was detected,
and in extracts of transfected cells we detected a highly abun-
dant component of identical size (105 kDa), showing that the
GCC88 cDNA encoded a protein of identical size as the endog-
enous GCC88 (Fig. 3C). The additional, smaller components,
detected in the transfected cell extracts, probably represent
degradation products of the overexpressed GCC88.
Anti-GCC185 antibodies detected a specific component of
175 kDa in HeLa cell extracts by immunoblotting, and like
GCC88, was also associated with both membrane and cytosolic
fractions (Fig. 3B). A size of 175 kDa is consistent with the
expected size of GCC185. The additional band observed at 130
kDa was considered nonspecific as it was also detected in the
control blots with pre-immune serum and varied in intensity
between samples. The anti-GCC185 antibodies also recognized
a specific 175-kDa component in COS cell extracts and, fur-
thermore, showed strong reactivity with an identical 175-kDa-
sized component in COS cells transfected with the full-length
GCC185 (Fig. 3C). These data confirm that the antibody raised
to the GST fusion protein specifically recognizes endogenous
GCC185 and that the cDNA clone is full-length.
Four Human GRIP Proteins Are Localized to the TGN of
HeLa Cells—By immunofluorescence, anti-GCC88 antibodies
showed strong juxtanuclear staining of HeLa cells (Fig. 4, A
and B), a typical staining of the Golgi apparatus. Staining of
HeLa cells with rabbit antibodies to GCC88 and human au-
toantibodies to p230 showed that GCC88 co-localized exten-
sively with p230, a known TGN protein (20). On the other
hand, GCC88 showed only minimum overlap with the cis-Golgi
marker GM130 (Fig. 4B), indicating that GCC88 is localized to
the trans region of the Golgi apparatus. Likewise, endogenous
GCC185 and golgin97 also co-localize to a large extent with
p230 (Fig. 4, C and D), indicating that all four golgins may be
targeted to the membranes of the trans-Golgi/TGN.
To more precisely localize GCC88 and GCC185 in HeLa cells,
cryofixed HeLa cells were labeled by the immunogold tech-
nique. Only very limited labeling for endogenous GCC88 and
GCC185 was observed (not shown), therefore HeLa cells were
transfected with myc-tagged full-length constructs, and trans-
fected cells were labeled with anti-myc antibodies. For GCC88,
gold labeling was found specifically associated with one side of
the Golgi stack (Fig. 5A). The labeled region was identified as
the TGN by the presence of co-labeling of syntaxin 6, a TGN-
specific soluble N-ethylmaleimide-sensitive factor attachment
protein receptor (SNARE) (26) that labeled membranes in the
FIG. 4. Endogenous GCC88, GCC185,
and golgin97 colocalize with p230 in
HeLa cells. Semiconfluent HeLa cell
monolayers were fixed, permeabilized,
and stained for GCC88 and p230 (A),
GCC88 and GM130 (B), GCC185 and
p230 (C), and golgin97 and p230 (D), us-
ing rabbit anti-GCC88, human anti-p230
antibody, mouse monoclonal anti-GM130,
rabbit anti-GCC185, and mouse mono-
clonal anti-golgin97 antibody. Bound an-
tibody was detected with either anti-rab-
bit IgG-Texas Red or anti-rabbit Ig-FITC
or Alexa594- or FITC-anti-human IgG.
A–C, monolayers were fixed in paraform-
aldehyde and in cold methanol (D). Con-
focal images were collected with identical
iris settings. Superimposed images (Over-
lay) reveal regions of co-localization. Con-
trol incubations demonstrated no cross-
reactivity between the anti-Ig conjugates
or between the anti-Ig conjugates and the
irrelevant primary antibody. Similar re-
sults were obtained irrespective of the or-
der of the primary antibodies. Bar, 10 m.
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same region (Fig. 5B). myc-GCC185 was also found associated
with tubulovesicular structures in the TGN, consistent with
the immunofluorescence data (Fig. 5C). Antibodies to golgin97
were unsuitable for immunogold labeling of cryosections. GFP
labeling of cryofixed GFP-golgin97GRIP-transfected HeLa cells
was located to one side, the TGN side, of the Golgi stack
associated with tubulovesicular structures (Fig. 5D). The ma-
jority of the Golgi cisternae were unlabeled. We have shown
previously (16, 20) that p230 and the p230 GRIP domain are
localized to the TGN. Taken together, these data show that all
four GRIP proteins are localized to the trans-Golgi/TGN.
Golgi Membrane Binding of GCC88 and GCC185 Is Brefeldin
A-sensitive—Previously, we showed that p230 is slowly disso-
ciated from HeLa Golgi membranes in the presence of brefeldin
A (20). We have compared the dissociation rate of p230, GCC88,
and GCC185 from Golgi membranes in the presence of this
drug. Immunofluorescence staining was carried out on HeLa
cells treated with brefeldin A for various times. There was no
effect on the perinuclear localization of GCC88 after a 5-min
brefeldin A treatment; by 15 min of treatment, however, there
was a reduction in perinuclear staining of GCC88, together
with an increase in the cytoplasmic staining (Fig. 6). Similar
rates of dissociation of GCC185 from Golgi membranes were
observed in the presence of brefeldin A (not shown). In contrast,
and as expected, -COP was mostly dissociated from Golgi
membranes within 2 min of treatment (Fig. 6). The relatively
slow rate of dissociation of GCC88 and GCC185 is similar to
that observed previously for p230 and distinguishes these pro-
teins from most other brefeldin A-sensitive peripheral mem-
brane Golgi proteins that dissociate from the membrane
rapidly.
Overexpression of Full-length GCC88 Results in an Abnor-
mal Structure of a Domain of the TGN—In the course of exper-
iments expressing full-length GCC88 we noted that although
low levels of expression showed GCC88 localized to the typical
juxtanuclear Golgi pattern, at higher levels of expression
GCC88-labeled structures began to extend out from the Golgi
region. The size of these structures was dependent on the level
of expression of GCC88. Fig. 7 shows a series of three-dimen-
sional reconstructions of Z-series images to illustrate the topol-
ogy of these structures and the relationship to the level of
GCC88 protein. The GCC88-labeled structures extend from the
Golgi, and at high levels of protein, the GCC88 structures
totally enclose the nucleus (see Fig. 7). By immunofluorescence
FIG. 6. GCC88 dissociates slowly from Golgi membranes after
brefeldin A treatment of HeLa cells. HeLa cells were either un-
treated (0 min) or incubated for 2 min, 5 min, 10 min, or 15 min with 5
g/ml brefeldin A at 37 °C. Cells were then fixed, permeabilized, and
stained for GCC88 or -COP, as indicated.
FIG. 5. myc-tagged GCC88 and
GCC185 and GFP-golgin97GRIP local-
ize to the trans-Golgi/TGN. Cells tran-
siently transfected with myc-GCC88,
myc-GCC185, or GFP-golgin97GRIP were
fixed by paraformaldehyde and processed
for cryoelectron microscopy. Ultra thin
cryosections were labeled with mono-
clonal antibody 9E10 (myc) alone (A–C) or
antibodies to GFP alone (D) or double la-
beled with monoclonal antibodies to myc
and to syntaxin 6 (syn6) (B). Antibodies
were detected with 5–15 nm protein A
gold particles or goat anti-mouse gold con-
jugates. Note that in each case gold label-
ing is found in the vicinity of the Golgi
complex (G) concentrated on the TGN
side of the stack. Syntaxin 6 (arrowheads)
and anti-myc antibodies labeled mem-
branes of the TGN. Bars, 100 nm.
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these GCC88-labeled structures resemble the appearance of
“cauliflowers.” The transfected HeLa cells containing the cau-
liflower-like structures were viable, as determined by pro-
pidium iodide staining 48 h after transfection.
The formation of the cauliflower phenotype was not observed
with the GFP-GCC88GRIP fusion protein. Overexpression of
GFP-GCC88GRIP results in saturation of Golgi membrane bind-
ing sites, and excess fusion protein is found in the cytoplasm. In
contrast the high levels of full-length GCC88 appear to be
inevitably recruited to the abnormal structures. To exclude the
possibility that the myc epitope was contributing to the forma-
tion of the abnormal structures we examined COS cells ex-
pressing untagged GCC88, as well as FLAG-tagged and GFP-
tagged GCC88. Substitution of the myc tag with either FLAG
or GFP resulted in the formation of the structures, as did
expression of untagged full-length GCC88 (not shown).
Next we examined the localization of a range of markers in
cells overexpressing GCC88, to identify molecules that were
affected by the cauliflower phenotype. GM130 staining was
unaffected in cells expressing high levels of GCC88, demon-
strating that the Golgi stack was not perturbed (Fig. 8A). The
resident TGN membrane protein, SialylT, was examined using
a stable HeLa cell line expressing VSV-G epitope-tagged Sia-
lylT (25). The SialylT expressing HeLa cells were transiently
transfected with GCC88. In transfected cells expressing low
levels of GCC88, there was almost complete co-localization of
GCC88 and SialylT, consistent with the TGN location of
GCC88 (Fig. 8B, arrows). In transfected cells displaying a mild
cauliflower phenotype SialylT remained tightly perinuclear
and showed little overlap with GCC88 (Fig. 8B, inset). In trans-
fected cells with a more extreme cauliflower phenotype the
SialylT staining pattern showed a more punctate staining pat-
tern; however, the SialylT staining pattern did not overlap with
the GCC88-labeled structures (Fig. 8B). These results indicate
FIG. 7. Overexpression of GCC88 results in a morphological
phenotype. HeLa cells were transfected with myc-GCC88, fixed, per-
meabilized, and stained with anti-myc monoclonal antibody followed by
FITC-anti-mouse Ig. Nuclei were stained with propidium iodide. Shown
are a series of three-dimensional reconstructions of Z-series images of
transfected cells expressing low to high levels of GCC88. Bar, 10 m.
FIG. 8. Distribution of Golgi markers in HeLa cells expressing
high levels of GCC88. HeLa cells were transiently transfected with
myc-GCC88, fixed, permeabilized, and co-stained for GCC88 and
GM130 (A), p230 (C), golgin97 (D), or -COP (E). In B, HeLa cells,
stably expressing SialylT fused to the VSV-G epitope, were transiently
transfected with myc-GCC88, fixed, permeabilized, and co-stained for
GCC88 and VSV-G epitope-tagged SialylT. In F, NRK cells were tran-
siently transfected with myc-GCC88, fixed, permeabilized, and co-
stained for GCC88 and TGN38. GCC88 was detected with rabbit anti-
GCC88 antibodies followed by Texas Red-goat anti-rabbit IgG. GM130,
epitope-tagged SialylT, golgin97, -COP, and TGN38 were detected
with mouse monoclonal antibodies, and bound antibodies were detected
with FITC-labeled sheep anti-mouse Ig. In C, p230 was detected with
human anti-p230 antibodies and FITC-goat anti-human IgG. In each
case, the marker was labeled first and GCC88 was labeled second.
Shown are images of transfected cells expressing high levels of GCC88.
Superimposed images (Overlay) reveal regions of co-localization. In B,
arrows indicate cells expressing low levels of GCC88. Control incuba-
tions demonstrated no cross-reactivity between the anti-Ig conjugates
and the irrelevant primary antibody. Bars, 10 m.
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that the TGN resident membrane protein SialylT is not re-
cruited into the GCC88-labeled structures.
Dual labeling of high expressing GCC88 cells for endogenous
p230 and golgin97 showed considerable co-staining, whereas,
the coat protein -COP retained its typical staining pattern
and was not localized to the GCC88-labeled cauliflower struc-
tures (Fig. 8, C–E). To investigate whether molecules that
recycle through the TGN were incorporated into the cauliflower
structures we stained GCC88-transfected NRK cells for the
membrane protein TGN38. At low levels of GCC88 expression,
extensive co-localization of GCC88 and TGN38 was observed
(not shown). This result was expected as TGN38 is predomi-
nantly located within the TGN (27). Significantly, at high levels
of GCC88 expression, TGN38 was also localized within the
cauliflower structures (Fig. 8F), clearly demonstrating that the
GCC88-labeled structures include recycling membrane
proteins.
By electron microscopy, myc-tagged GCC88 transfected cells
displayed electron dense structures in close proximity to the
trans-face of the Golgi, and in some cells these structures were
found to extend some distance from the Golgi stack (Fig. 9, A
and B). Immunolabeling for GCC88 with anti-myc antibodies
revealed GCC88 decorated tubulovesicular structures associ-
ated with the TGN, as well as giving heavy labeling of the
electron dense structures adjacent to the TGN membranes.
Both the tubulovesicular structures and the electron dense
structures were co-labeled with syntaxin 6, confirming that the
GCC88-labeled structures are either TGN membranes or de-
rived therefrom. The large electron dense structures are highly
ordered and label very strongly with either anti-myc antibodies
FIG. 9. Overexpression of GCC88
leads to the formation of aberrant
structures extending from the TGN.
HeLa cells were transfected with myc-
GCC88 and cells fixed with glutaralde-
hyde and processed for cryoelectron mi-
croscopy. Ultra thin cryosections were
double labeled with monoclonal antibod-
ies to myc and rabbit polyclonal antibod-
ies to GCC88 (A) or double labeled with
monoclonal antibodies to myc and to syn-
taxin 6 (syn6) (arrows) (B) or labeled with
antibodies to syntaxin 6 or myc alone (C
and D, respectively). Antibodies were de-
tected with 5–10 nm protein A gold parti-
cles. Inset in A shows lower magnification
of electron dense GCC88-labeled struc-
tures. Note the labeling of structures that
are in close proximity to the TGN. Bars,
100 nm.
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or anti-GCC antibodies (Fig. 9A). Labeling of GCC88 was ob-
served predominantly on the outside of the high density protein
arrays. The structures are composed of highly ordered electron
dense arrays, and lipid bilayers were not readily visible in
these structures. The high level of immunogold labeling indi-
cates that the electron dense structures in these transfected
cells are because of close packing of GCC88 molecules.
Cauliflower Phenotype Is Dependent on Coiled-coil Regions
and the N Terminus of GCC88—Overexpression of GFP-
GCC88GRIP does not result in the generation of abnormal phe-
notype, rather at high levels of expression of the GRIP fusion
protein the membrane binding sites are saturated, and excess
GFP fusion protein is found distributed throughout the cyto-
plasm (Fig. 10). To determine whether the N-terminal domain
is required for the formation of the cauliflower structures, a
deletion mutant was constructed lacking the 279 N-terminal
residues. The myc-GCC88280–775 mutant showed Golgi local-
ization, as expected, but high levels of expression showed no
evidence of abnormal Golgi staining, and the GCC88 deletion
mutant was localized both on the Golgi and in the cytoplasm,
analogous to the behavior of the GFP-GRIP fusion protein (Fig.
10). Therefore, the non-coiled-coil N-terminal domain is re-
quired to generate the abnormal phenotype.
TGN38 Traffics through GCC88-labeled Structures—The
localization of TGN38 to the GCC88-labeled cauliflower
structures may represent a pool of TGN38 molecules that are
blocked in transport or alternatively may represent TGN38
molecules that are in transit through a subdomain of the
TGN. To determine whether the cauliflower structures can
receive membrane cargo molecules, we traced TGN38 mole-
cules from the cell surface of NRK cells to the TGN by
incubation of live cells with anti-TGN38 monoclonal anti-
body. After the incubation, cells were washed to remove un-
bound antibody, and the TGN38/antibody complexes were
detected using FITC-anti-mouse Ig. Incubation of NRK cells
with anti-TGN38 antibodies on ice showed low level staining
of cell surface TGN38 and no co-localization of TGN38 and
the GCC88-stained structures (Fig. 11A). Incubation of un-
transfected cells with anti-TGN38 antibody at 37 °C showed
co-localization of TGN38 with endogenous GCC88, confirm-
ing the movement of TGN38 from the cell surface to the TGN
(Fig. 11F). Incubation of GCC88-transfected NRK cells with
anti-TGN38 antibody at 37 °C for 10 min resulted in the
localization of the antibody-TGN38 complex within GCC88-
labeled cauliflower structures (Fig. 11B). Further incubation
at 37 °C for 90 min showed an increase in antibody-TGN38
complex detected within the GCC88 structures (Fig. 11C). On
the other hand, incubation of the cells at 37 °C for 90 min
with an irrelevant monoclonal antibody showed only a low
level internalization of the antibody, demonstrating that the
uptake of anti-TGN38 antibody was specific (Fig. 11E). This
result demonstrates that TGN38 is transported from the cell
surface into the subdomain of the TGN that has been per-
turbed by the overexpression of full-length GCC88.
To determine whether TGN38 can be transported out of the
cauliflower structures, live transfected NRK cells were loaded
with antibody to TGN38, incubated at 37 °C for 90 min to chase
the antibody-TGN38 complexes into the TGN/cauliflowers,
washed to remove unbound antibody in the medium, and then
incubated further for 45 min in the presence of bafilomycin A1.
FIG. 10. Aberrant structures induced by high levels of GCC88
are dependent on the N-terminal domain of GCC88. Confocal
fluorescence images of fixed COS cells transfected with GFP-
GCC88GRIP, myc-GCC881–775, or myc-GCC88280–775 as indicated. myc-
GCC88 products were detected with anti-myc monoclonal antibody
followed by FITC-anti-mouse Ig. Transfected cells were fixed 48 h after
transfection. Bars, 10 m.
FIG. 11. Cell surface TGN38 is transported into enlarged GCC88-labeled structures. NRK cells were transfected with myc-GCC88. The
cells were then washed in PBS and incubated in serum-free medium containing anti-TGN38 (1.25 g/ml) (A–D) or a control monoclonal antibody
(E) on ice for 10 min (A), 37 °C for 10 min (B), or 37 °C for 90 min (C and E). In D, NRK cells transfected with myc-GCC88 were incubated with
anti-TGN38 antibodies for 90 min at 37 °C and then washed and incubated further for 45 min at 37 °C in serum-free medium containing 0.2 M
bafilomycin A1. F, untransfected cells were incubated with anti-TGN38 antibody at 37 °C for 90 min. Monolayers were fixed and permeabilized,
and the TGN38-Ig complex was detected with FITC-anti-mouse Ig and stained for GCC88 using rabbit anti-GCC88 antibodies followed by Texas
Red goat anti-rabbit IgG. Bars, 10 m.
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If antibody-TGN38 complexes can be transported out of the
GCC88-labeled structures, their subsequent transport from en-
dosomes should then be blocked by balifolmycin A1 (28). Incu-
bation of antibody-loaded GCC88-transfected cells in the pres-
ence of balifolmycin A showed a significant reduction of TGN38
in the cauliflower structures with additional staining in endo-
somes (Fig. 11D). This result indicates that the TGN38 mole-
cules that had been transported into the GCC88-labeled struc-
tures could be transported from these structures to the plasma
membrane and then internalized into endosomes. Thus, the
GCC88 decorated cauliflowers appear to represent a subdo-
main of the TGN that can accommodate movement of mem-
brane cargo molecules.
DISCUSSION
Based on the presence of putative Golgi targeting GRIP
sequences, we have identified two novel human trans-Golgi/
TGN proteins, designated GCC88 and GCC185. Both proteins
have structural features similar to other members of the GRIP
family of proteins, namely extensive coiled-coil regions
throughout the polypeptide and the GRIP domain located at
the C terminus. We have demonstrated that the GRIP domains
of GCC88 and GCC185 are functional Golgi targeting se-
quences and furthermore, that these proteins and another
member of the GRIP family, golgin97, are localized, together
with p230, to the trans-Golgi/TGN. Thus we can conclude that
there are four human proteins with GRIP domains associated
with the TGN of HeLa cells. Overexpression of GCC88 induced
a dramatic enlargement of a domain of the TGN through which
the membrane protein TGN38 could recycle, suggesting that
GCC88 may function to maintain the organization of a TGN
domain involved with membrane transport.
GCC88 was initially identified based on a GRIP sequence in
the data base. Here we isolated cDNA clones and established
that the clones encode the full-length sequence of GCC88, as
rabbit antibodies raised against a bacterial fusion protein rec-
ognized an endogenous protein in HeLa and COS cell extracts
of the same size as that encoded by the cloned cDNA. Likewise,
we established that the human cDNA clone (HG1120; gene
name KIAA0336) encodes a protein of the same size as the
endogenous GCC185 protein, confirming that the clone is full-
length. GCC88 and GCC185 were shown to be bona fide Golgi
proteins with similar membrane binding characteristics as
p230. GCC88 and GCC185 are peripheral membrane proteins
as both (1) are associated with both cytosol and membrane
fractions, (2) dissociate from Golgi membranes in the presence
of brefeldin A, and (3) lack a signal sequence or membrane-
spanning domain. The relatively slow rate of brefeldin A-in-
duced dissociation of GCC88 and GCC185 from Golgi mem-
branes is very similar to the behavior of p230 (20, 22) and
clearly distinguishes the GRIP proteins from many other
brefeldin A-sensitive proteins, such as -COP, that dissociate
rapidly (2 min) after treatment. The membrane binding of the
different GRIP proteins therefore appears to be regulated in a
similar, as yet undefined, manner. The kinetics of GRIP protein
dissociation from the Golgi indicates that the action of brefeldin
A on the G protein, ARF, occurs considerably upstream from
GRIP protein dissociation or that there are additional unde-
fined targets of brefeldin A.
The sequence similarity between the GRIP domains is only
modest. The data presented here and elsewhere (12–14) col-
lectively show that four different human GRIP sequences are
functional Golgi targeting signals. In view of the modest
sequence similarity between GRIP domains it was possible
that different GRIPs may have distinct fine specificities and
may be localized to different regions of the Golgi. By immu-
nofluorescence and immunogold labeling we demonstrated
that GCC88, GCC185, and the GRIP domain of golgin97 are
all localized to the trans-Golgi/TGN. A TGN localization for
GCC88 and golgin97 is consistent with earlier studies that
showed that GFP fused to the GRIP domain of GCC88 (pre-
viously GCC1p) or golgin97 was able to displace endogenous
p230 from Golgi membranes when present at high levels in
transfected cells (13). The finding here that the four GRIP
proteins are indeed localized to the TGN raises the possibility
that the different family members may compete for the same
TGN membrane determinants. The mechanism of GRIP bind-
ing to Golgi membranes appears to be highly conserved
throughout evolution as GRIP sequences are also functional
in yeast (14) and the primitive eucaryotic organism, Leish-
mania (17). However, the membrane determinants for GRIP
domains remain to be identified.
The function of GRIP proteins has not been clearly defined.
The predominance of coiled-coil structures is highly suggestive
of rod-like molecules and furthermore links the GRIP proteins
to other coiled-coil proteins of the golgin family that are pro-
posed to function in the organization of the Golgi and as mo-
lecular tethers in the docking of transport vesicles with target
membranes (21). Recent studies have shown that endogenous
p230 and a GFP fusion protein containing the p230-GRIP se-
quence are recruited to a subdomain of the TGN that forms
dynamic tubular extensions that have the characteristics of
transport carriers (16). In addition, GFP-p230 GRIP associates
with a population of in vitro generated vesicles (16), consistent
with a potential role of p230 as a tethering molecule for vesicle
docking or for attachment of the transport carriers to the cy-
toskeleton. A membrane transport role has also been impli-
cated for Imh1p, a GRIP protein from S. cerevisiae (19).
Surprisingly, the overexpression of GCC88 in transfected
cells induced considerable morphological change, namely a dra-
matic enlargement of Golgi-associated structures. The develop-
ment of these cauliflower structures was independent of cell
type and the epitope tag present on the full-length GCC88. The
abnormal structures, which extended from the trans-face of the
Golgi apparatus, contained large amounts of GCC88 protein
that appeared as regularly packed arrays in electron micro-
graphs. Although no membrane bilayers could be seen in the
arrays in cryosections, the presence of TGN38 and syntaxin 6
clearly indicates the inclusion of membrane in these structures.
The high content of GCC88 on these structures indicates that
full-length GCC88 may be able to self-associate to form highly
ordered oligomers, possibly via their coiled-coil regions, on the
surface of the membrane, in contrast to the GFP fusion protein
containing only the GRIP domain, which readily saturates the
Golgi membrane binding sites. Analysis of deletion mutants
showed that the N-terminal domain of GCC88 is required to
induce the morphological change in the TGN. The requirement
for the non-coiled-coil N-terminal domain raises the possibility
that the interaction of full-length GCC88 with other molecules
is necessary to generate the perturbation of the TGN. Overall,
our data show that the organization of the TGN is dependent
on maintaining the appropriate level of GCC88 in the cell.
At the light microscopic level the GCC88-labeled structures
resemble abnormal outgrowths of endoplasmic reticulum mem-
branes produced by overexpression of the cis-Golgi membrane
protein p23/24 (29). At the ultrastructural level, however, there
is little similarity between the p23 and GCC88 structures.
Significantly, both abnormal structures are examples of how
compartments can be morphologically perturbed by changing
levels of critical organizational proteins.
Overexpression of GCC88 did not affect the entire TGN
compartment as the membrane resident protein SialylT did not
co-localize with the cauliflower structures whereas TGN38 can
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move into and from the GCC88 decorated structures. These
findings imply that resident TGN proteins may be sorted into
domain(s) distinct from membrane molecules in transit
through the TGN. The finding that a resident TGN protein is
excluded from the abnormal structures suggests that the
GCC88 decorated cauliflowers are derived from TGN domains
associated with membrane transport. Other studies have also
indicated that the TGN exists as subdomains; for example the
TGN-associated proteins p230 and p200/myosin II are found on
distinct tubulovesicular structures (20); however, the underly-
ing molecular basis for maintaining the complex network of
tubular structures is poorly understood. The behavior of
GCC88 suggests that this molecule may be involved in main-
taining the organization of a subdomain of the TGN.
The basis for the formation of the cauliflower structures
remains unclear. The GCC88 decorated structures are not sen-
sitive to brefeldin A,2 suggesting that GCC88 overexpression
may result in oligomers that are insensitive to G protein reg-
ulation, thereby perturbing dissociation of GCC88 from the
membrane. Of note is that overexpression of other Golgi mol-
ecules involved in linking membranes to the cytoskeleton, such
as CLIPR-59 and GMAP-210, also dramatically affects Golgi
morphology (30, 31). One possibility is that GCC88 is involved
in maintaining the tubular network of the TGN compartment
via interactions with the membrane and cytoskeleton. High
levels of GCC88 may result in drawing TGN membranes from
a tightly packed network into an open structure as a result of
enhanced interactions with the cytoskeleton. Such an open
structure would occupy a larger unit volume of the cell com-
pared with a compact tubular network, consistent with the
appearance of the GCC88-labeled structures. Thus, GCC88
may function as a TGN matrix protein to help maintain the
tubular extensions of the TGN, structures likely to be required
for efficient sorting and transport. The cauliflower-like struc-
tures present in cells expressing high levels of GCC88 clearly
allow the transport of cargo, but it is possible that the efficiency
of sorting and/or transport may be affected. Further experi-
ments to determine the rates of recycling and exocytosis from
the TGN will be required to address these possibilities.
Why are four different GRIP proteins expressed in one cell
type? Each of the GRIP proteins may have a different function,
or alternatively, there may be overlap between the functions of
the four members. Further experiments defining the molecular
basis for the generation of abnormal TGN structures by GCC88
should provide insight into the precise role of GCC88 and other
GRIP proteins in maintaining the complex organization of the
TGN.
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